公司資料
iCAD, Inc. 股價、新聞與催化劑
已下市
- 股票代碼:
- ICAD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 ICAD 的收盤價變動背景。
公司概覽
業務概覽
iCAD is a medical imaging and cancer-detection company focused on AI-enabled breast health and workflow software. Its business sits at the intersection of imaging, detection, and software.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, iCAD sits in medtech and diagnostics.
商業模式特徵
The company depends on product adoption, imaging workflow integration, and the monetization of its cancer-detection platform.
生技產業定位
iCAD is outside biotech and belongs to the imaging and diagnostics layer.
未來催化劑
- iCAD’s catalysts are ProFound AI adoption and breast-cancer detection workflow growth. The market will care about whether AI mammography keeps translating into durable clinical usage.
近期新聞
新聞標題由機器翻譯,詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。
